Assessment of two commercial susceptibility test methods for determination of daptomycin MICs

被引:22
作者
Jorgensen, JH [1 ]
Crawford, SA [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
关键词
D O I
10.1128/JCM.00076-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Daptomycin is a lipopeptide antibiotic with activity against several important gram-positive bacterial pathogens, including drug-resistant staphylococci and enterococci. Because the mechanism of action of daptomycin is calcium-dependent depolarization of the cell membrane, susceptibility testing requires medium supplemented with a physiological level of calcium. This study assessed two Food and Drug Administration-cleared commercial test devices for determination of daptomycin MICs, Etest and JustOne. A collection of 220 selected isolates, including Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, E. faecium, E. avium, E. durans, E. casseliflavus, and E. gallinarum, were tested by both methods. Included in the collection were 22 S. aureus and 14 Enterococcus sp. isolates that were recovered from patients and were nonsusceptible on the basis of the daptomycin MICs. As the reference method for comparison, all isolates were tested by the Clinical and Laboratory Standards Institute broth microdillution method incorporating cation-adjusted Mueller-Hinton broth with 50 mu g/ml calcium. Daptomycin MICs agreed, within I twofold dilution, for 97% of the isolates by Etest and for 100% by JustOne. However, daptomycin MICs determined by Etest were I dilution lower than the reference MICs for 65% of the Enterococcus sp. isolates tested. This resulted in 28.5% very major (VM) errors (4/14) with enterococci (all E. faecium) but none (0/22) with staphylococci. Use of JustOne yielded MICs that were I dilution lower than the reference MICs for 69% of the staphylococci and 25% of the enterococci. This resulted in 13.6% VM errors (3/22) with staphylococci and 14.3% VM errors (2/14) with enterococci. The manufacturer-recommended JustOne inoculum preparation resulted in mean colony counts of only 5 X 10(4) to 1 X 10(5) CFU/ml in the wells of the strip. Increasing the inoculum to 3 X 105 to 4 X 105 CFU/ml eliminated two of five VM errors upon retesting. No major interpretive errors occurred with either device. In summary, daptomycin MICs generated by the Etest or JustOne method generally agreed within I dilution of the reference daptomycin MICs. However, both devices produced slightly lower MICs that resulted in some VM errors.
引用
收藏
页码:2126 / 2129
页数:4
相关论文
共 16 条
[1]   Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations [J].
Akins, RL ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :454-459
[2]   DAPTOMYCIN DISRUPTS MEMBRANE-POTENTIAL IN GROWING STAPHYLOCOCCUS-AUREUS [J].
ALBORN, WE ;
ALLEN, NE ;
PRESTON, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2282-2287
[3]  
[Anonymous], 2006, METH DIL ANT SUSC TE
[4]   The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections [J].
Arbeit, RD ;
Maki, D ;
Tally, FP ;
Campanaro, E ;
Eisenstein, BI .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1673-1681
[5]   In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers [J].
Barry, AL ;
Fuchs, PC ;
Brown, SD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1919-1922
[6]  
Clinical and Laboratory Standards Institute, 2006, M100S16 CLIN LAB STA
[7]   Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus [J].
Hayden, MK ;
Rezai, K ;
Hayes, RA ;
Lolans, K ;
Quinn, JP ;
Weinstein, RA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) :5285-5287
[8]   In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium [J].
Jevitt, LA ;
Smith, AJ ;
Williams, PP ;
Raney, PM ;
McGowan, JE ;
Tenover, FC .
MICROBIAL DRUG RESISTANCE, 2003, 9 (04) :389-393
[9]   Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar [J].
Johnson, AP ;
Mushtaq, S ;
Warner, M ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :860-862
[10]   In vitro activity of daptomycin against vancomycin-resistant enterococci of various van types and comparison of susceptibility testing methods [J].
Jorgensen, JH ;
Crawford, SA ;
Kelly, CC ;
Patterson, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) :3760-3763